Sun Pharma Advanced Research Company Limited has informed the Exchange regarding a revised press release dated December 10, 2021, titled "SPARC to present updated clinical data of vodobatinib (SCO-088) at the 63rd ASH annual meeting".
Press Release (Revised) Dec 10 2021
Filed with NSE ·
6ix hasn’t read this filing yet.
Sun Pharma Advanced Research Co. Ltd. on 6ix
In the deck
Earlier from Sun Pharma Advanced Research
- Press Release Dec 10 2021
- Update on SPARC strategy and portfolio
- Press Release Dec 08 2021
- SPARC Licenses Development and Commercialization Rights of PDP-716 and SDN-037 to Visiox Pharma
- Press Release Dec 03 2021
Later from Sun Pharma Advanced Research
- Corporate Presentation
- FY 2021-22
- AGM Speech 2021-22
- Press Release Sep 29 2022
- Outcome of committee meeting
Follow Sun Pharma Advanced Research into a list and get an email when it puts out news.
Follow Sun Pharma Advanced Research